Moderna (MRNA) surged 100% intraday with market cap topping $50 billion; Merck (MRK) rose 10% to an intraday all-time high and BioNTech rose 17.6%, after Moderna and Merck announced successful melanoma vaccine research.
Jin1008/19, 08:39 PM
Related assets
Coming up for MRNA
Explore next
ZeroHedge08/19, 09:26 PM
ZeroHedge commented that Moderna (MRNA) surged and dominated market momentum intraday.